&#226;€‹Biopharmaceutical company
Expressing support for changes to the CREATES Act (H.R. 2212, S. 974) and Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051). Analyzing the impact of SOUND Disposal and Packaging Act (HR 5687), the Opioid Crisis Response Act of 2018 (S. 2680), and the Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act" (the "SCREEN Act"), H.R. 5228.
PHA - Pharmacy
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
COVINGTON & BURLING LLP
850 10th Street, NW, Washington, DC, 20001, US
WILLIAM WICHTERMAN GABRIEL NEVILLE KRISTA CARVER CHRISTINA KUHN